E

EXUMA Biotech

28 employees

EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
CAR-T
cell therapy
Immuno-Oncology
Big Data
CAR-NK
gene therapy
Medical
viral engineering
oncology

Date founded

2015

Funding rounds raised

Total raised

$41M

from 4 investors over 4 rounds

E

EXUMA Biotech raised $41M on December 21, 2021

Investors: Ohio State Life Insurance - purchased by Americo Financial Life and Annuity

E

EXUMA Biotech raised $19M on March 12, 2020

Investors: BDT & MSD Partners

E

EXUMA Biotech raised $10M on January 8, 2018

Investors: Shanghai PerHum Therapeutics Co., Ltd

E

EXUMA Biotech raised $37M on February 16, 2017

Investors: 上海旭珩资产管理有限公司

FAQ